Home >> Our Doctors >> Adult Urology Specialists >> Daniel G. Benson, M.D.

urology grapevine, urology southlake, urology colleyville, Dr. Daniel Benson, urology, Colleyville, Flower Mound, Keller, Grapevine, Trophy Club, Westlake, Roanoke, North Richland Hills, Watauga, Hurst, Euless, Bedford, Denton, Decatur, Lewisville

Daniel G. Benson, M.D.

Urologist

Click here for driving directions to his office in Dallas.

Main Office in Dallas

3417 Gaston Avenue, Suite 830
Dallas, Texas 75246

214-826-6021 Tel
214-823-9745 Fax

[Top]

Quick bio links: Education | Board-certification | Honor and Awards | Professional Memberships | Publications | Podium Presentations | Poster Presentations

Education:

  • The University of Texas Health Science Center, San Antonio, TX
    Doctor of Medicine, 2007 – 2011

Specialty Training:

  • University of Alabama at Birmingham
    Department of Urology, 2012 – 2016
  • University of Alabama at Birmingham
    Department of General Surgery, 2011 – 2012

Other Education:

  • Southern Methodist University, Dallas, TX
    Bachelor of Science in Biology, 2003 – 2006
  • Boston College, Chestnut Hill, MA
    2002 – 2003

Licenses and Certifications:

  • Texas Medical Board
  • Alabama State Board of Medical Examiners

Honors / Awards:

  • Alpha Omega Alpha, Inductee 2011
  • Jack R. Robison Scholarship for Urology

Professional Memberships and Societies:

  • American Urological Association
  • Alpha Omega Alpha

Publications:

  • Shim EH, Livi CB, Rakheja D, Tan J, Benson D, Parekh V, Kho EY, Ghosh AP, Kirkman R, Velu S, Dutta S, Chenna B, Rea SL, Mishur RJ, Li Q, Johnson-Pais TL, Guo L, Bae S, Wei S, Block K, Sudarshan S. L- 2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov. 2014 Nov; 4(11): 1290-8.
  • Chang JJ, Youn TS, Benson D, Mattick H, Andrade N, Harper CR, Moore CB, Madden CJ, Diaz-Arrastia RR. Physiologic and functional outcome correlates of brain tissue hypoxia in traumatic brain injury. Crit Care Med. 2009 Jan; 37(1): 371-2.

[Top]

Podium Presentations:

  • Tan J, Benson D, Shim EH, Sudarshan S. L-2-Hydroxyglutarate: a putative oncometabolite in clear cell renal cell carcinoma. Podium presentation. AUA Southeastern Section Annual Meeting. Savannah, GA, March 2015.
  • Gayheart D, Hughes CT, Benson D, Kapadia A, Sudarshan S. Pyruvate dehydrogenase kinase-1 inhibitors potentiate the anti-tumor activity of TKIs against renal carcinoma cells. Podium presentation. AUA Southeastern Section Annual Meeting. Hollywood, FL, March 2014.

[Top]

Poster Presentations:

  • Gayheart D, Hughes T, Benson D, Kapadia A, Sudarshan S. The contribution of oncometabolite remodeling to therapy resistance in renal cancer. AUA Annual Meeting. Orlando, FL, May 2014.
  • Shim, E, Livi C, Knight J, Holmes R, Rakheja D, Velu S, Kho E, Chenna B, Rea S, Benson D, Kirkman R, Ghosh A, Li Q, Bae S, Wei S, Block K, Sudarshan S. Elevated (L)-2-hydroxyglutarate promotes loss of 5- hydroxymethylcytosine in clear cell renal cancer. American Association for Cancer Research Annual Meeitng. San Diego, CA, April 2014.
  • Benson D and Corneille M. Predictors of Pulmonary Embolism in Critically Ill Trauma Patients. UTHSCSA Medical Student Research Day, University of Texas Health Science Center, San Antonio, TX. Fall 2008.
  • Diaz-Arrastia R, Moore C, Benson D, Meltzer E, Punnoose J, Womack K, McColl R. Diffusion Tensor Magnetic Resonance Imaging (DTI-MRI) of Aging and Dementia: Comparison with FLAIR Demonstrates Increased Sensitivity for White Matter Pathology. 5th Leonard Berg Symposium, Alzheimer’s Disease Research Center, Washington University, St. Louis, MO. Oct 2005.

[Top]